{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["MDR1)", "P-glycoprotein (ABCB1", "differential scanning calorimetry (DSC)", "isobavachalcone", "model membrane", "molecular modeling", "multidrug resistance (MDR)", "phospholipid bilayer", "prenylated chalcone"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34361789", "DateCompleted": {"Year": "2021", "Month": "09", "Day": "17"}, "DateRevised": {"Year": "2021", "Month": "09", "Day": "17"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "07", "Day": "30"}], "Language": ["eng"], "ELocationID": ["4637", "10.3390/molecules26154637"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "26", "Issue": "15", "PubDate": {"Year": "2021", "Month": "Jul", "Day": "30"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Isobavachalcone as an Active Membrane Perturbing Agent and Inhibitor of ABCB1 Multidrug Transporter.", "Abstract": {"AbstractText": ["Isobavachalcone (IBC) is an active substance from the medicinal plant <i>Psoralea corylifolia</i>. This prenylated chalcone was reported to possess antioxidative, anti-inflammatory, antibacterial, and anticancer activities. Multidrug resistance (MDR) associated with the over-expression of the transporters of vast substrate specificity such as ABCB1 (P-glycoprotein) belongs to the main causes of cancer chemotherapy failure. The cytotoxic, MDR reversing, and ABCB1-inhibiting potency of isobavachalcone was studied in two cellular models: human colorectal adenocarcinoma HT29 cell line and its resistant counterpart HT29/Dx in which doxorubicin resistance was induced by prolonged drug treatment, and the variant of MDCK cells transfected with the human gene encoding ABCB1. Because MDR modulators are frequently membrane-active substances, the interaction of isobavachalcone with model phosphatidylcholine bilayers was studied by means of differential scanning calorimetry. Molecular modeling was employed to characterize the process of membrane permeation by isobavachalcone. IBC interacted with ABCB1 transporter, being a substrate and/or competitive inhibitor of ABCB1. Moreover, IBC intercalated into model membranes, significantly affecting the parameters of their main phospholipid phase transition. It was concluded that isobavachalcone interfered both with the lipid phase of cellular membrane and with ABCB1 transporter, and for this reason, its activity in MDR cancer cells was presumptively beneficial."]}, "AuthorList": [{"Identifier": ["0000-0002-4246-5717"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biophysics and Neuroscience, Wroclaw Medical University, ul. Chalubinskiego 3a, 50-368 Wroclaw, Poland."}], "LastName": "Palko-\u0141abuz", "ForeName": "Anna", "Initials": "A"}, {"Identifier": ["0000-0001-9610-7598"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biophysics and Neuroscience, Wroclaw Medical University, ul. Chalubinskiego 3a, 50-368 Wroclaw, Poland."}], "LastName": "B\u0142aszczyk", "ForeName": "Maria", "Initials": "M"}, {"Identifier": ["0000-0003-3454-5044"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biophysics and Neuroscience, Wroclaw Medical University, ul. Chalubinskiego 3a, 50-368 Wroclaw, Poland."}], "LastName": "\u015aroda-Pomianek", "ForeName": "Kamila", "Initials": "K"}, {"Identifier": ["0000-0003-1659-3288"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biophysics and Neuroscience, Wroclaw Medical University, ul. Chalubinskiego 3a, 50-368 Wroclaw, Poland."}], "LastName": "Weso\u0142owska", "ForeName": "Olga", "Initials": "O"}], "GrantList": [{"GrantID": "SUB.A400.21.040", "Agency": "Uniwersytet Medyczny im. Piast\u00f3w Slaskich we Wroclawiu", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "ABCB1 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "ATP Binding Cassette Transporter, Subfamily B"}, {"RegistryNumber": "0", "NameOfSubstance": "Antibiotics, Antineoplastic"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Chalcones"}, {"RegistryNumber": "0", "NameOfSubstance": "Drug Combinations"}, {"RegistryNumber": "0", "NameOfSubstance": "Lipid Bilayers"}, {"RegistryNumber": "0", "NameOfSubstance": "Membranes, Artificial"}, {"RegistryNumber": "0", "NameOfSubstance": "Phosphatidylcholines"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "20784-50-3", "NameOfSubstance": "isobavachalcone"}, {"RegistryNumber": "80168379AG", "NameOfSubstance": "Doxorubicin"}, {"RegistryNumber": "CJ0O37KU29", "NameOfSubstance": "Verapamil"}], "MeshHeadingList": [{"QualifierName": ["antagonists & inhibitors", "genetics", "metabolism"], "DescriptorName": "ATP Binding Cassette Transporter, Subfamily B"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antibiotics, Antineoplastic"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": [], "DescriptorName": "Binding, Competitive"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Chalcones"}, {"QualifierName": [], "DescriptorName": "Dogs"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Doxorubicin"}, {"QualifierName": [], "DescriptorName": "Drug Combinations"}, {"QualifierName": ["drug effects", "genetics"], "DescriptorName": "Drug Resistance, Neoplasm"}, {"QualifierName": [], "DescriptorName": "Gene Expression"}, {"QualifierName": [], "DescriptorName": "HT29 Cells"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Inhibitory Concentration 50"}, {"QualifierName": ["chemistry", "metabolism"], "DescriptorName": "Lipid Bilayers"}, {"QualifierName": [], "DescriptorName": "Madin Darby Canine Kidney Cells"}, {"QualifierName": [], "DescriptorName": "Membranes, Artificial"}, {"QualifierName": [], "DescriptorName": "Models, Molecular"}, {"QualifierName": ["chemistry", "metabolism"], "DescriptorName": "Phosphatidylcholines"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Protein Binding"}, {"QualifierName": ["chemistry"], "DescriptorName": "Psoralea"}, {"QualifierName": [], "DescriptorName": "Transgenes"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Verapamil"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Chopra B., Dhingra A.K., Dhar K.L. Psoralea corylifolia L. (Buguchi)\u2014folklore to modern evidence: Review. Fitoterapia. 2013;90:44\u201356. doi: 10.1016/j.fitote.2013.06.016.", "ArticleIdList": ["10.1016/j.fitote.2013.06.016", "23831482"]}, {"Citation": "Khushboo P.S., Jadhav V.M., Kadam V.J., Sathe N.S. Psoralea corylifolia Linn.-\u201cKushtanashini\u201d. Pharmacogn. Rev. 2010;4:69\u201376. doi: 10.4103/0973-7847.65331.", "ArticleIdList": ["10.4103/0973-7847.65331", "PMC3249905", "22228944"]}, {"Citation": "Kuete V., Ngameni B., Mbaveng A.T., Ngadjui B., Marion Meyer J.J., Lall N. Evaluation of flavonoids from Dorstenia barteri for their antimycobacterial, antigonorrheal and anti-reverse transcriptase activities. Acta Trop. 2010;116:100\u2013104. doi: 10.1016/j.actatropica.2010.06.005.", "ArticleIdList": ["10.1016/j.actatropica.2010.06.005", "20599632"]}, {"Citation": "Solnier J., Fladerer J.P. Flavonoids: A complementary approach to conventional therapy of COVID-19? Phytochem. Rev. 2020;18:1\u201323. doi: 10.1007/s11101-020-09720-6.", "ArticleIdList": ["10.1007/s11101-020-09720-6", "PMC7500502", "32982616"]}, {"Citation": "Dzoyem J.P., Hamamoto H., Ngameni B., Ngadjui B.T., Sekimizu K. Antimicrobial action mechanism of flavonoids from Dorstenia species. Drug Discov. Ther. 2013;7:66\u201372. doi: 10.5582/ddt.2013.v7.2.66.", "ArticleIdList": ["10.5582/ddt.2013.v7.2.66", "23715504"]}, {"Citation": "Kuete V., Ngameni B., Tangmouo J.G., Bolla J.M., Alibert-Franco S., Ngadjui B.T., Pages J.M. Efflux pumps are involved in the defense of Gram-negative bacteria against the natural products isobavachalcone and diospyrone. Antimicrob. Agents Chemother. 2010;54:1749\u20131752. doi: 10.1128/AAC.01533-09.", "ArticleIdList": ["10.1128/AAC.01533-09", "PMC2863662", "20160051"]}, {"Citation": "ElSohly H.N., Joshi A.S., Nimrod A.C., Walker L.A., Clark A.M. Antifungal chalcones from Maclura tinctoria. Planta Med. 2001;67:87\u201389. doi: 10.1055/s-2001-10621.", "ArticleIdList": ["10.1055/s-2001-10621", "11270732"]}, {"Citation": "Jing H., Zhou X., Dong X., Cao J., Zhu H., Lou J., Hu Y., He Q., Yang B. Abrogation of Akt signaling by isobavachalcone contributes to its anti-proliferative effects towards human cancer cells. Cancer Lett. 2010;294:167\u2013177. doi: 10.1016/j.canlet.2010.01.035.", "ArticleIdList": ["10.1016/j.canlet.2010.01.035", "20167420"]}, {"Citation": "Kuete V., Mbaveng A.T., Zeino M., Fozing C.D., Ngameni B., Kapche G.D., Ngadjui B.T., Efferth T. Cytotoxicity of three naturally occurring flavonoid derived compounds (artocarpesin, cycloartocarpesin and isobavachalcone) towards multi-factorial drug-resistant cancer cells. Phytomedicine. 2015;22:1096\u20131102. doi: 10.1016/j.phymed.2015.07.006.", "ArticleIdList": ["10.1016/j.phymed.2015.07.006", "26547532"]}, {"Citation": "Jin X., Shi Y.I. Isobavachalcone induces the apoptosis of gastric cancer cells via inhibition of the Akt and Erk pathways. Exp. Ther. Med. 2016;11:403\u2013408. doi: 10.3892/etm.2015.2904.", "ArticleIdList": ["10.3892/etm.2015.2904", "PMC4734064", "26893622"]}, {"Citation": "Haraguchi H., Inoue J., Tamura Y., Mizutani K. Antioxidative components of Psoralea corylifolia (Leguminosae) Phytother. Res. 2002;16:539\u2013544. doi: 10.1002/ptr.972.", "ArticleIdList": ["10.1002/ptr.972", "12237811"]}, {"Citation": "Morgan A.M.A., Lee H.W., Lee S.H., Lim C.H., Jang H.D., Kim Y.H. Anti-osteoporotic and antioxidant activities of chemical constituents of the aerial parts of Ducrosia ismaelis. Bioorg. Med. Chem. Lett. 2014;24:3434\u20133439. doi: 10.1016/j.bmcl.2014.05.077.", "ArticleIdList": ["10.1016/j.bmcl.2014.05.077", "24953601"]}, {"Citation": "Shin H.J., Shon D.H., Youn H.S. Isobavachalcone suppresses expression of inducible nitric oxide synthase induced by Toll-like receptor agonists. Int. Immunopharmacol. 2013;15:38\u201341. doi: 10.1016/j.intimp.2012.11.005.", "ArticleIdList": ["10.1016/j.intimp.2012.11.005", "23164691"]}, {"Citation": "Kim D.H., Li H., Han Y.E., Jeong J.H., Lee H.J., Ryu J.H. Modulation of inducible nitric oxide synthase expression in LPS-stimulated BV-2 microglia by prenylated chalcones from Cullen corylifolium (L.) Medik. through inhibition of I-\u03baB\u03b1 degradation. Molecules. 2018;23:109. doi: 10.3390/molecules23010109.", "ArticleIdList": ["10.3390/molecules23010109", "PMC6017879", "29300354"]}, {"Citation": "Chen X., Yang Y., Zhang Y. Isobavachalcone and bavachinin from Psoraleae Fructus modulate A\u03b242 aggregation process through different mechanisms in vitro. FEBS Lett. 2013;587:2930\u20132935. doi: 10.1016/j.febslet.2013.07.037.", "ArticleIdList": ["10.1016/j.febslet.2013.07.037", "23907009"]}, {"Citation": "Xiao S., Wu Q., Yao X., Zhang J., Zhong W., Zhao J., Liu Q., Zhang M. Inhibitory effects of isobavachalcone on tau protein aggregation, tau phosphorylation, and oligomeric tau-induced apoptosis. ACS Chem. Neurosci. 2021;12:123\u2013132. doi: 10.1021/acschemneuro.0c00617.", "ArticleIdList": ["10.1021/acschemneuro.0c00617", "33320518"]}, {"Citation": "Gottesman M.M. Mechanisms of cancer drug resistance. Ann. Rev. Med. 2002;53:615\u2013627. doi: 10.1146/annurev.med.53.082901.103929.", "ArticleIdList": ["10.1146/annurev.med.53.082901.103929", "11818492"]}, {"Citation": "Sharom F.J. ABC multidrug transporters: Structure, function and role in chemoresistance. Pharmacogenomics. 2008;9:105\u2013127. doi: 10.2217/14622416.9.1.105.", "ArticleIdList": ["10.2217/14622416.9.1.105", "18154452"]}, {"Citation": "Ford J.M., Hait W.N. Pharmacologic circumvention of multidrug resistance. Cytotechnology. 1993;12:171\u2013212. doi: 10.1007/BF00744664.", "ArticleIdList": ["10.1007/BF00744664", "7765325"]}, {"Citation": "Li W., Zhang H., Assaraf Y.G., Zhao K., Xu X., Xie J., Yang D.H., Chen Z.S. Overcoming ABC transporter-mediated multidrug resistance: Molecular mechanisms and novel therapeutic drug strategies. Drug Resist. Updates. 2016;27:14\u201329. doi: 10.1016/j.drup.2016.05.001.", "ArticleIdList": ["10.1016/j.drup.2016.05.001", "27449595"]}, {"Citation": "Shukla S., Wu C.P., Ambudkar S.V. Development of inhibitors of ATP-binding cassette drug transporters: Present status and challenges. Expert Opin. Drug Metab. Toxicol. 2008;4:205\u2013223. doi: 10.1517/17425255.4.2.205.", "ArticleIdList": ["10.1517/17425255.4.2.205", "18248313"]}, {"Citation": "Di Pietro A., Conseil G., Perez-Victoria J.M., Dayan G., Baubichon-Cortay H., Trompier D., Steinfels E., Jault J.M., de Wet H., Maitrejean M., et al. Modulation by flavonoids of cell multidrug resistance mediated by P-glycoprotein and related ABC transporters. Cell. Mol. Life Sci. 2002;59:307\u2013322. doi: 10.1007/s00018-002-8424-8.", "ArticleIdList": ["10.1007/s00018-002-8424-8", "11915946"]}, {"Citation": "Wesolowska O., Wisniewski J., Sroda K., Krawczenko A., Bielawska-Pohl A., Paprocka M., Dus D., Michalak K. 8-Prenylnaringenin is an inhibitor of multidrug resistance-associated transporters, P-glycoprotein and MRP1. Eur. J. Pharmacol. 2010;644:32\u201340. doi: 10.1016/j.ejphar.2010.06.069.", "ArticleIdList": ["10.1016/j.ejphar.2010.06.069", "20633549"]}, {"Citation": "Shilling R.A., Venter H., Velamakanni S., Bapna A., Woebking B., Shahi S., van Veen H.W. New light on multidrug binding by an ATP-binding-cassette transporter. Trends Pharmacol. Sci. 2006;27:195\u2013203. doi: 10.1016/j.tips.2006.02.008.", "ArticleIdList": ["10.1016/j.tips.2006.02.008", "16545467"]}, {"Citation": "Chufan E.E., Sim H.M., Ambudkar S.V. Molecular basis of the polyspecificity of P-glycoprotein (ABCB1): Recent biochemical and structural studies. Adv. Cancer Res. 2015;125:71\u201396. doi: 10.1016/bs.acr.2014.10.003.", "ArticleIdList": ["10.1016/bs.acr.2014.10.003", "PMC7709800", "25640267"]}, {"Citation": "Higgins C.F., Gottesman M.M. Is the multidrug transporter a flippase? Trends Biochem. Sci. 1992;17:18\u201321. doi: 10.1016/0968-0004(92)90419-A.", "ArticleIdList": ["10.1016/0968-0004(92)90419-A", "1374941"]}, {"Citation": "Storch C.H., Ehehalt R., Haefeli W.E., Weiss J. Localization of the human breast cancer resistance protein (BCRP/ABCG2) in lipid rafts/caveolae and modulation of its activity by cholesterol in vitro. J. Pharmacol. Exp. Ther. 2007;323:257\u2013264. doi: 10.1124/jpet.107.122994.", "ArticleIdList": ["10.1124/jpet.107.122994", "17652262"]}, {"Citation": "Sharom F.J. Complex interplay between the P-glycoprotein multidrug efflux pump and the membrane: Its role in modulating protein function. Front. Oncol. 2014;4:41. doi: 10.3389/fonc.2014.00041.", "ArticleIdList": ["10.3389/fonc.2014.00041", "PMC3939933", "24624364"]}, {"Citation": "Pajeva I.K., Wiese M., Cordes H.P., Seydel J.K. Membrane interactions of some catamphiphilic drugs and relation to their multidrug-resistance-reversing ability. J. Cancer Res. Clin. Oncol. 1996;122:27\u201340. doi: 10.1007/BF01203070.", "ArticleIdList": ["10.1007/BF01203070", "8543589"]}, {"Citation": "Song M., Liu Y., Li T., Liu X., Hao Z., Ding S., Panichayupakaranant P., Zhu K., Shen J. Plant natural flavonoids against multidrug resistant pathogens. Adv. Sci. 2021:2100749. doi: 10.1002/advs.202100749.", "ArticleIdList": ["10.1002/advs.202100749", "PMC8336499", "34041861"]}, {"Citation": "Arczewska M., Kaminski D.M., Gorecka E., Pociecha D., Roj E., S\u0142awinska-Brych A., Gagos M. The molecular organization of prenylated flavonoid xanthohumol in DPPC multibilayers: X-ray diffraction and FTIR spectroscopic studies. Biochim. Biophys. Acta. 2013;1828:213\u2013222. doi: 10.1016/j.bbamem.2012.10.009.", "ArticleIdList": ["10.1016/j.bbamem.2012.10.009", "23085000"]}, {"Citation": "Wesolowska O., Gasiorowska J., Petrus J., Czarnik-Matusewicz B., Michalak K. Interaction of prenylated chalcones and flavanones from common hop with phosphatidylcholine model membranes. Biochim. Biophys. Acta. 2014;1838:173\u2013184. doi: 10.1016/j.bbamem.2013.09.009.", "ArticleIdList": ["10.1016/j.bbamem.2013.09.009", "24060562"]}, {"Citation": "Hendrich A.B., Malon R., Pola A., Shirataki Y., Motohashi N., Michalak K. Differential interaction of Sophora isoflavonoids with lipid bilayers. Eur. J. Pharm. Sci. 2002;16:201\u2013208. doi: 10.1016/S0928-0987(02)00106-9.", "ArticleIdList": ["10.1016/S0928-0987(02)00106-9", "12128175"]}, {"Citation": "Yusa K., Tsuruo T. Reversal mechanism of multidrug resistance by verapamil: Direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells. Cancer Res. 1989;49:5002\u20135006.", "ArticleIdList": ["2569930"]}, {"Citation": "Riganti C., Miraglia E., Viarisio D., Costamagna C., Pescarmona G., Ghigo D., Bosia A. Nitric oxide reverts the resistance to doxorubicin in human colon cancer cells by inhibiting the drug efflux. Cancer Res. 2005;65:516\u2013525.", "ArticleIdList": ["15695394"]}, {"Citation": "Weaver J.L., Szabo G., Pine P.S., Gottesman M.M., Goldenberg S., Aszalos A. The effect of ion channel blockers, immunosuppressive agents, and other drugs on the activity of the multi-drug transporter. Int. J. Cancer. 1993;54:456\u2013461. doi: 10.1002/ijc.2910540317.", "ArticleIdList": ["10.1002/ijc.2910540317", "7685326"]}, {"Citation": "Voet D., Voet J.G. Biochemistry. 4th ed. John Wiley & Sons; New York, NY, USA: 2010. pp. 399\u2013418."}, {"Citation": "Lomize A.L., Hage J.M., Schnitzer K., Golobokov K., LaFaive M.B., Forsyth A.C., Pogozheva I.D. PerMM: A web tool and database for analysis of passive membrane permeability and translocation pathways of bioactive molecules. J. Chem. Inf. Model. 2019;59:3094\u20133099. doi: 10.1021/acs.jcim.9b00225.", "ArticleIdList": ["10.1021/acs.jcim.9b00225", "PMC6781619", "31259547"]}, {"Citation": "Mealey K.L., Barhoumi R., Burghardt R.C., Safe S., Kochevar D.T. Doxycycline induces expression of P glycoprotein in MCF-7 breast carcinoma cells. Antimicrob. Agents Chemother. 2002;46:755\u2013761. doi: 10.1128/AAC.46.3.755-761.2002.", "ArticleIdList": ["10.1128/AAC.46.3.755-761.2002", "PMC127468", "11850258"]}, {"Citation": "Palko-\u0141abuz A., \u015aroda-Pomianek K., Weso\u0142owska O., Kostrzewa-Sus\u0142ow E., Uryga A., Michalak K. MDR reversal and pro-apoptotic effects of statins and statins combined with flavonoids in colon cancer cells. Biomed. Pharmacother. 2019;109:1511\u20131522. doi: 10.1016/j.biopha.2018.10.169.", "ArticleIdList": ["10.1016/j.biopha.2018.10.169", "30551403"]}, {"Citation": "Palko-Labuz A., Sroda-Pomianek K., Uryga A., Kostrzewa-Suslow E., Michalak K. Anticancer activity of baicalein and luteolin studied in colorectal adenocarcinoma LoVo cells and in drug-resistant LoVo/Dx cells. Biomed. Pharmacother. 2017;88:232\u2013241. doi: 10.1016/j.biopha.2017.01.053.", "ArticleIdList": ["10.1016/j.biopha.2017.01.053", "28110189"]}, {"Citation": "Riganti C., Rolando B., Kopecka J., Campia I., Chegaev K., Lazzarato L., Federico A., Fruttero R., Ghigo D. Mitochondrial-targeting nitrooxy-doxorubicin: A new approach to overcome drug resistance. Mol. Pharm. 2013;10:161\u2013174. doi: 10.1021/mp300311b.", "ArticleIdList": ["10.1021/mp300311b", "23186264"]}, {"Citation": "Li K., Zheng Q., Chen X., Wang Y., Wang D., Wang J. Isobavachalcone induces ROS-mediated apoptosis via targeting thioredoxin reductase 1 in human prostate cancer PC-3 cells. Oxid. Med. Cell. Longev. 2018;2018:1915828. doi: 10.1155/2018/1915828.", "ArticleIdList": ["10.1155/2018/1915828", "PMC6206523", "30410640"]}, {"Citation": "Li B., Xu N., Wan Z., Ma L., Li H., Cai W., Chen X., Huang Z., He Z. Isobavachalcone exerts anti-proliferative and pro-apoptotic effects on human liver cancer cells by targeting the ERKs/RSK2 signaling pathway. Oncol. Rep. 2019;41:3355\u20133366. doi: 10.3892/or.2019.7090.", "ArticleIdList": ["10.3892/or.2019.7090", "30942462"]}, {"Citation": "Li Y., Qin X., Li P., Zhang H., Lin T., Miao Z., Ma S. Isobavachalcone isolated from Psoralea corylifolia inhibits cell proliferation and induces apoptosis via inhibiting the AKT/GSK-3\u03b2/\u03b2-catenin pathway in colorectal cancer cells. Drug Des. Dev. Ther. 2019;13:1449\u20131460. doi: 10.2147/DDDT.S192681.", "ArticleIdList": ["10.2147/DDDT.S192681", "PMC6503305", "31118579"]}, {"Citation": "Nishimura R., Tabata K., Arakawa M., Ito Y., Kimura Y., Akihisa T., Nagai H., Sakuma A., Kohno H., Suzuki T. Isobavachalcone, a chalcone constituent of Angelica keiskei, induces apoptosis in neuroblastoma. Biol. Pharm. Bull. 2007;30:1878\u20131883. doi: 10.1248/bpb.30.1878.", "ArticleIdList": ["10.1248/bpb.30.1878", "17917255"]}, {"Citation": "Wang H.M., Zhang L., Liu J., Yang Z.L., Zhao H.Y., Yang Y., Shen D., Lu K., Fan Z.C., Yao Q.W., et al. Synthesis and anti-cancer activity evaluation of novel prenylated and geranylated chalcone natural products and their analogs. Eur. J. Med. Chem. 2015;92:439\u2013448. doi: 10.1016/j.ejmech.2015.01.007.", "ArticleIdList": ["10.1016/j.ejmech.2015.01.007", "25590864"]}, {"Citation": "Hendrich A.B., Wesolowska O., Motohashi N., Molnar J., Michalak K. New phenothiazine-type multidrug resistance modifiers: Anti-MDR activity versus membrane perturbing potency. Biochem. Biophys. Res. Commun. 2003;304:260\u2013265. doi: 10.1016/S0006-291X(03)00580-1.", "ArticleIdList": ["10.1016/S0006-291X(03)00580-1", "12711308"]}, {"Citation": "Jain M.K., Wu N.M. Effect of small molecules on the dipalmitoyl lecithin liposomal bilayer: III. Phase transition in lipid bilayer. J. Membr. Biol. 1977;34:157\u2013201. doi: 10.1007/BF01870299.", "ArticleIdList": ["10.1007/BF01870299"]}, {"Citation": "Bae S.J., Kitamura S., Herbette L.G., Sturtevant J.M. The effects of calcium channel blocking drugs on the thermotropic behavior of dimyristoylphosphatidylcholine. Chem. Phys. Lipids. 1989;51:1\u20137. doi: 10.1016/0009-3084(89)90059-5.", "ArticleIdList": ["10.1016/0009-3084(89)90059-5", "2766431"]}, {"Citation": "Mason R.P., Mak I.T., Trumbore M.W., Mason P.E. Antioxidant properties of calcium antagonists related to membrane biophysical interactions. Am. J. Cardiol. 1999;84:16L\u201322L. doi: 10.1016/S0002-9149(99)00360-4.", "ArticleIdList": ["10.1016/S0002-9149(99)00360-4", "10480441"]}, {"Citation": "Canaves J.M., Ferragut J.A., Gonzalez-Ros J.M. Verapamil prevents the effects of daunomycin on the thermotropic phase transition of model lipid bilayers. Biochem. J. 1991;279:413\u2013418. doi: 10.1042/bj2790413.", "ArticleIdList": ["10.1042/bj2790413", "PMC1151620", "1953639"]}, {"Citation": "Meier M., Li Blatter X., Seelig A., Seelig J. Interaction of verapamil with lipid membranes and P-glycoprotein: Connecting thermodynamics and membrane structure with functional activity. Biophys. J. 2006;91:2943\u20132955. doi: 10.1529/biophysj.106.089581.", "ArticleIdList": ["10.1529/biophysj.106.089581", "PMC1578493", "16877510"]}, {"Citation": "Pajeva I., Todorov D.K., Seydel J. Membrane effects of the antitumor drugs doxorubicin and thaliblastine: Comparison to multidrug resistance modulators verapamil and trans-flupentixol. Eur. J. Pharm. Sci. 2004;21:243\u2013250. doi: 10.1016/j.ejps.2003.10.013.", "ArticleIdList": ["10.1016/j.ejps.2003.10.013", "14757496"]}, {"Citation": "Lomize A.L., Pogozheva I.D. Physics-based method for modeling passive membrane permeability and translocation pathways of bioactive molecules. J. Chem. Inf. Model. 2019;59:3198\u20133213. doi: 10.1021/acs.jcim.9b00224.", "ArticleIdList": ["10.1021/acs.jcim.9b00224", "PMC6756154", "31259555"]}, {"Citation": "Pastan I., Gottesman M.M., Ueda K., Lovelace E., Rutherford A.V., Willingham M.C. A retrovirus carrying an MDR1 cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells. Proc. Natl. Acad. Sci. USA. 1988;85:4486\u20134490. doi: 10.1073/pnas.85.12.4486.", "ArticleIdList": ["10.1073/pnas.85.12.4486", "PMC280455", "2898143"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "7", "Day": "7"}, {"Year": "2021", "Month": "7", "Day": "26"}, {"Year": "2021", "Month": "7", "Day": "29"}, {"Year": "2021", "Month": "8", "Day": "7", "Hour": "1", "Minute": "11"}, {"Year": "2021", "Month": "8", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "9", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "7", "Day": "30"}], "PublicationStatus": "epublish", "ArticleIdList": ["34361789", "PMC8347294", "10.3390/molecules26154637", "molecules26154637"]}}], "PubmedBookArticle": []}